DE:TEL1 Stock Latest News
Company AnnouncementsSihuan’s Anaprazole Shows Strong Phase III Results in Reflux Esophagitis1w ago
Company AnnouncementsSihuan Pharmaceutical Wins Hong Kong Approval for Key Medical Aesthetic Products1w ago
Company AnnouncementsSihuan Pharmaceutical Invests in Canton Biologics to Build Full-Chain Regenerative Aesthetics Platform3w ago
Company AnnouncementsSihuan Pharmaceutical Expands Dongyan Skin Booster Dosage Range to Strengthen Aesthetics Portfolio3w ago
Company AnnouncementsSihuan’s Xuanzhu Biopharm Strikes Exclusive Bireociclib Deal in Thailand1M ago
Company AnnouncementsSihuan Pharmaceutical Grants 116 Million Performance-Based Share Awards2M agoCompany AnnouncementsSihuan Pharmaceutical Reshapes Leadership With CFO Exit and New Non-Executive Director2M ago
Company AnnouncementsSihuan Pharmaceutical Clarifies Board and Committee Structure2M ago- Company AnnouncementsSihuan Pharmaceutical Leans on Aesthetics and Innovation as Generic Drug Margins Erode2M ago
Company AnnouncementsSihuan Pharmaceutical Sets Board Meeting to Approve Interim Results and Dividend Plan2M ago
Company AnnouncementsSihuan Pharmaceutical Updates Bermuda Registered Office Address3M ago
Company AnnouncementsSihuan Pharmaceutical Flags 217% Profit Surge on Medical Aesthetics and Portfolio Gains3M agoCompany AnnouncementsSihuan’s Xuanzhu Wins NMPA NDA Acceptance for New Reflux Esophagitis Use of Anaprazole4M ago
Company AnnouncementsSihuan Pharmaceutical Shareholders Approve All AGM Resolutions and Capital Mandates4M ago
Company AnnouncementsSihuan’s Xuanzhu Biopharm Launches Phase III Trial for Anaprazole in H. pylori Therapy4M ago- Company AnnouncementsSihuan Pharmaceutical Buys Shares for Award Scheme as Medical Aesthetics Surges4M ago
Company AnnouncementsSihuan Pharmaceutical Buys Shares for Award Scheme as Medical Aesthetics Drives Profitable Growth5M ago- Company AnnouncementsSihuan Pharmaceutical Sets 2026 AGM to Approve FY2025 Results, Dividend and Share Issuance Mandate5M ago
Company AnnouncementsSihuan Pharmaceutical Forms AI-Driven Medical Aesthetics JV with dProtein5M agoCompany AnnouncementsSihuan Pharma Buys Shares for Award Scheme as Medical Aesthetics Drives Profit Turnaround5M ago
Company AnnouncementsSihuan Pharmaceutical Launches Share Buyback as Medical Aesthetics Surge Drives Return to Profit5M ago
